Mounting evidence indicates that microRNAs (miRNAs) play important roles in the control of glial cell development in the central nervous system. Suppression of miRNA formation disrupts the initial generation of oligodendrocyte progenitor cells from the ventricular neuroprogenitor cells in the embryonic spinal cord. miRNAs also regulate the later events of oligodendrocyte development, including cell proliferation, maturation, and myelin formation. In addition, miRNAs are essential for the development of astrocytes, and inhibition of miRNA genesis completely blocks astrogliogenesis in the spinal cord.
Neuroscience Update
During early development, neurons and glia are sequentially produced from neural epithelial or progenitor cells in the ventricular zone throughout the entire CNS, with neurogenesis preceding gliogenesis (Miller 2002; Richardson and others 2006; Rowitch 2004) . It has been well documented that different domains of progenitor cells generate distinct types of neurons and glia (oligodendrocytes or astrocytes) (Lu and others 2002; Takebayashi and others 2002; Zhou and Anderson 2002) . In the developing spinal cord, neural epithelial cells in the motor neuron progenitor domain (pMN) produce motor neurons from E9.0 to E12.5 followed by oligodendrocyte progenitor cells (OPCs or OLPs) from E12.5 to E15.5 ( Fig. 1 ; Rowitch 2004) . Other progenitor domains give rise to various types of interneurons followed by astroglia. During gliogenesis, early OPCs delaminate from the ventricular zone and subsequently undergo nondirectional migration to populate all regions of the CNS before they differentiate into mature myelinating oligodendrocytes (Lu and others 2000; Zhou and Anderson 2000) . In contrast, astroglia appear to reach their final destinations through radial migration and differentiate locally (Houchstim and others 2008) .
miRNAs Are Essential for the Initiation of Oligodendrogenesis in the Spinal Cord
Although much has been known about the spatiotemporal events of neurogenesis and gliogenesis in the developing CNS, one remaining outstanding question in developmental neurobiology is how the binary switch from neurogenesis to gliogenesis is temporally controlled at the molecular level. The molecular pathways that instruct neural progenitor cells to turn off neurogenesis and at the same time to turn on gliogenesis remain to be identified. Our recent studies have demonstrated that microRNA (miRNA) molecules play a crucial role in the initiation of the gliogenic process.
miRNAs are small noncoding RNA molecules that are processed from longer RNA precursors through cleavage by the ubiquitously expressed Dicer RNase (Carthew and Sontheimer 2009) . They function as the negative regulators of posttranscriptional gene expression (Ouellet and others 2006) by binding to the 3′-untranslational region of specific mRNA targets, directing their degradation and/or repressing their translation (He and Hannon 2004) . Recent studies have demonstrated that miRNAs control lineage-specific development and functioning of various cell types in both animals and plants (Banerjee and Slack 2002; De Pietri Tonelli and others 2008) . In the developing central nervous system, miRNAs display abundant and selective expression in undifferentiated neural progenitor cells in the ventricular zone and their progeny cells (neurons and glia) (Cao and others 2007; Farrell and others 2010) , raising the possibility that miRNA-regulated gene expression participates in the early fate specification and differentiation of neurons and glia. This possibility has been recently examined in Olig1 cre / Dicer flox/flox conditional mutants in which the Dicer gene (aka miRNAs) was selectively ablated in the Olig1expressing ventral spinal neuroepithelium, including the pMN and p3 domains ( Fig. 1 ). In these conditional mutants, expression of several neural progenitor genes, including Olig2, in this region is normal, and motor neuron production is not affected, indicating that miRNAs are not critical for the early neural patterning and neurogenesis in the developing spinal cord (Zheng and others 2010). However, generation of early OPC cells from the pMN domain during early gliogenic stages (E12.5-E14.5) was nearly completely blocked ( Fig. 2A,B ; Zheng and others 2010). More recent follow-up studies demonstrate that at later stages, a small number of OPCs are produced from the dorsal region of the mutant spinal cord ( Fig. 2C,D) , and these dorsally derived OPC cells continue to proliferate for an expansion of progenitor cells (Cai and others 2005; Vallstedt and others 2005) . By the time of birth, the number of OPCs in the mutants is comparable to that in the normal embryos ( Fig. 2E,F) . However, expression of mature oligodendrocyte markers MBP and PLP is not detected in the Dicer mutants ( Fig. 2G,H) . The lack of MBP/PLP expression is likely to be secondary to the defective OPC generation, as the differentiation defect is also observed in other genetic mutants (e.g., Nkx6-/-, Gli2-/-) with retarded OPC generation from the pMN domain (Qi and others 2001; Liu R and others 2003; Cai and others 2005) . Together, these results indicate that miRNA formation is essential for the initiation of OPC generation in the ventral spinal cord. Intriguingly, the inhibition of oligodendrogenesis is not associated with the extension of motor neuron generation (no supernumerary motor neurons are detected in the Dicer mutants), suggesting that neurogenesis and gliogenesis can be uncoupled and may be controlled by distinct molecular mechanisms.
miRNAs Regulate Oligodendrocyte Proliferation, Differentiation, and Myelin Maintenance in the CNS
As OPCs migrate away from the ventricular zone into the surrounding regions, they continue to proliferate in response to the endogenous mitogen PDGF-A (Calver and others 1998; Fruttiger and others 1999) . The proliferation of OPCs appears to be modulated by miRNAs as well. MiR-219 negatively regulates the expression of PDGFRα in OPCs, and inhibition of miRNA formation in Dicer mutants leads to increased OPC numbers (Dugas and others 2010; Zhao and others 2010) . In contrast, the miR-17-92 cluster enhances OPC proliferation, and ablation of this miRNA cluster in OPCs results in a modest decrease in the number of OPCs (Budde and others 2010). The modulation of OPC division by the miR-17-92 cluster is mediated by activation of the PTEN/Akt pathway. As the cluster contains four miRNAs, it is not known yet which specific miRNA is directly involved in the regulation of OPC proliferation.
After OPCs migrate to the white matter region and adhere to axons, they start to undergo a series of morphological and molecular changes to become mature myelinating oligodendrocytes. Two recent studies demonstrated that expression of several miRNAs, most notably miR-219 and miR-338, is selectively up-regulated in differentiating white matter OPCs (Dugas and others 2010; Zhao and others 2010). Overexpression of these miRNAs in OPC cells promotes their differentiation in culture. Conversely, inhibition of the function of these miRNAs suppressed OPC differentiation and maturation in culture. These miRNAs seem to regulate oligodendrocyte maturation by repressing the expression of inhibitory factors such as Hes5, Id2/4, Sox6, and PDGFRα. Consistently, ablation of Dicer in oligodendrocytes with Olig1 Cre or Olig2 Cre results in a dramatic reduction of oligodendrocyte differentiation and myelin formation (Dugas and others 2010; Zhao and others 2010) . However, in view of the requirement of miRNAs for the initial generation of OPC cells (Fig. 2) , it is possible that the dramatic phenotypes observed in Olig1 Cre /Dicer flox/flox and Olig2 Cre /Dicer flox/flox might be attributed to the delayed and/or reduced OPC generation as well. In support of this notion, conditional disruption of Dicer in OPC cells in the CNP Cre /Dicer flox/flox mutants only have mild effect on oligodendrocyte differentiation (Dugas and others 2010; Fig. 3) , even though the expression of miR-219 is not detected in differentiating OPCs (Fig. 3) . Therefore, it remains plausible that miRNAs may fine-tune the timing of oligodendrocyte differentiation during normal development, in keeping with the previous observations that miR-219 target genes Hes5 and Sox6 regulate the timing of oligodendrocyte maturation (Kondo and Raff 2000) , and inactivation of these genes leads to premature oligodendrocyte maturation (Liu A and others 2006; Stolt and others 2006) . Genetic mutations of these maturation-specific miRNAs will further define their roles in the control of oligodendrocyte differentiation and myelination.
In addition, miRNA expression in mature oligodendrocytes is also required for the proper maintenance of myelin composition and structure. Conditional deletion of Dicer in mature myelinating oligodendrocytes using PLP-CreER T results in a dysregulation of the expression of miR-219 target gene Elov7 that is involved in lipid homeostasis, leading to increased demyelination and inflammatory neuronal damage (Shin and others 2009).
miRNAs Are Required for Astrogliogenesis in the Spinal Cord
In the developing spinal cord, astrocytes are produced from p1, p2, p3, and possibly other domains as well (Fig.  1; Houchstim and others 2008) . In Olig1 Cre/+ /Dicer flox/flox animals, expression of three general astrocyte markers (GFAP, ID3, and S100-β) was completely absent in a triangular region immediately flanking the floor plate ( Fig. 4A,B ; Zheng and others 2010), suggesting that the development of astrocytes derived from the ventral-most p3 domain was completely inhibited. Consistently, expression of the VA3 astrocyte (a subset of astrocytes derived from the p3 domain) marker Slit1 (Houchstim and others 2008) was also suppressed in the mutant spinal cord (Zheng and others 2010) . Similarly, conditional ablation of Dicer from the dorsal neuroepithelium in Pax3 cre /Dicer flox/flox mutants selectively eliminates the dorsal expression of astrocyte marker GFAP (Fig.  4C,D) . Together, these results clearly indicate that miR-NAs play an essential role in astrogliogenesis in the spinal cord and provide further evidence for the radial migration and distribution of astroglia in the spinal cord. However, due to the lack of early markers for astrocyte lineage, it is difficult to determine whether disruption of miRNA formation inhibits the initial generation or the terminal differentiation of astroglial cells. Also, it would be interesting and important to identify the specific miR-NAs and their target genes responsible for the development of astrocytes in the spinal cord.
Conclusion
miRNAs have been implicated in governing various aspects of cell development in plants and animals. Thus, it is not surprising to find that miRNAs control the devel-opment of glial cells at multiple stages, including fate specification, cell proliferation, terminal differentiation, myelin homeostasis, and maintenance. As the roles of miRNAs in glial genesis are gradually being unraveled, many important issues still remain to be addressed: (1) Although miRNAs are known to be essential for the initiation of gliogenesis, it is not clear what specific miRNA species are involved in the commencement of early gliogenic process. (2) miRNAs are indispensable for the onset of both oligodendrogenesis and astrogliogenesis in the spinal cord, but it remains to be investigated whether miRNAs are similarly required for gliogenesis in the forebrain and other CNS regions. (3) What signals or factors control the selective and dynamic expression of miRNA molecules in cells of glial lineage during development? Answering these issues will provide important insights into the molecular control of glial lineage progression and possibly the strategic design for promoting cell replacement and repair in CNS injuries and diseases.
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